INIS
therapy
100%
viruses
100%
oligonucleotides
100%
herpes simplex
100%
animals
57%
guinea pigs
57%
diseases
42%
mice
28%
humans
28%
control
28%
applications
28%
comparative evaluations
28%
inoculation
28%
administration
14%
in vitro
14%
data
14%
phosphates
14%
cavities
14%
single administration
14%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Oligonucleotide
100%
Herpes Simplex Virus 2
100%
Genital Herpes
100%
Animal
57%
Diseases
42%
Guinea Pig
42%
Mouse
28%
Human
28%
Absence
14%
Guinea Pig Model
14%
Survival Rate
14%
Phosphate Buffered Saline
14%
Aciclovir
14%
Thiophosphate
14%
Immunology and Microbiology
Genital Herpes
100%
Herpes Simplex Virus 2
100%
Animal
57%
Guinea Pig
42%
Nucleotide Sequence
42%
Mouse
28%
Human
28%
Immune Response
14%
Survival Rate
14%
Viral Shedding
14%
Guinea Pig Model
14%
Neuroscience
Oligonucleotide
100%
Herpes Simplex Virus
100%
Nucleic Acid Sequence
42%
Inoculation
28%
In Vitro
14%
Herpes
14%
Phosphate Buffered Saline
14%
Aciclovir
14%
Keyphrases
Immunostimulatory Sequences
100%